New eye drug aims to slow vision loss from dry macular degeneration
Disease control
Ongoing
This study tests an experimental drug called AVD-104, given as an eye injection, for people with geographic atrophy, a late stage of dry age-related macular degeneration that causes blind spots. The trial involves 300 participants and aims to see if the drug is safe and can slow …
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC